Researchers have developed an innovative nano-immune agonist that significantly improves immunotherapy outcomes for melanoma—a highly aggressive and hard-to-treat form of skin cancer. The study ...

Early detection of melanoma is crucial, as highlighted by the initial mole discovery and subsequent diagnosis. The journey involved surgery, immunotherapy, and targeted therapy, with challenges like ...

[212Pb]VMT01 is being tested in combination with Opdivo in a phase 1/2a trial for melanoma patients with positive MC1R imaging scans. The FDA granted fast track designation to [212Pb]VMT01 for ...

Close to 100 per cent of people who are diagnosed with non-melanoma skin cancer survive for at least five years after their diagnosis, according to a new report. For melanoma, the more serious ...

Researchers have uncovered a stealth survival strategy that melanoma cells use to evade targeted therapy, offering a promising new approach to improving treatment outcomes. Melanoma, the deadliest ...

Researchers have uncovered a stealth survival strategy that melanoma cells use to evade targeted therapy, offering a promising new approach to improving treatment outcomes. The study, published in ...

As skin cancer cases rise globally, experts urge individuals to monitor their skin regularly for any signs of melanoma, a type of skin cancer that originates in the melanocytes, the cells ...

She is scheduled for some tests. Her primary care physician believes it might be melanoma. What is melanoma? What treatment options are available, and is surgery necessary? Have there been recent ...

IGNORANCE about skin cancer — particularly melanoma — among Jamaicans has led to many patients being diagnosed with the disease at later stages, resulting in expensive treatment options and ...

This misconception has led to late diagnoses, higher mortality rates, and a lack of targeted education on the unique ways melanoma manifests in darker skin. Melanoma may be less common among Black ...

The treatment landscape for melanoma saw significant advancements in 2024, as highlighted by Elisa Funck-Brentano, MD, PhD, from Ambroise-Paré Hospital in Paris, France, during her presentation ...